Effect of supplementation in treatment of Coronary Heart Disease

Phase 2

• Conditions: Coronary Heart Disease.; Chronic ischemic heart disease, unspecified; I25.9

• Registration Number: IRCT20181029041490N1
• Lead Sponsor: Kashan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 October 2019

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

patients with T2DM, aged 40-85 years old with proven 2- and 3-vessel CHD

Exclusion Criteria

Consuming resveratrol three months prior to the intervention
Taking antioxidant and/or anti-inflammatory supplements such as vitamin E and vitamin C
Having an acute myocardial infarction or cardiac surgery in the past three months
Having renal or hepatic failure

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Insulin resistance. Timepoint: At the beginning of the study and after 4 weeks of intervention. Method of measurement: Calculation using HOMA formula.